What Happens to Type 1 Diabetes When People with Obesity Have Bariatric Surgery?

For people living with both Type 1 diabetes and obesity, weight management is challenging. Bariatric surgery—surgical procedures that reduce stomach size or alter how food is digested—has proven effective for weight loss in the general population. However, questions remain about how these procedures specifically affect people with Type 1 diabetes, whose insulin needs and blood sugar control can be complex and individual.

This study, conducted at Joslin Diabetes Center in Boston, directly compared what happened to 20 adults with Type 1 diabetes who had bariatric surgery against a matched group of 20 adults who received standard diabetes care. The researchers tracked participants for three years to see the longer-term effects.

The difference in weight outcomes between the two groups was striking. After three years, people who had bariatric surgery lost an average of 33.5 kg—about 28% of their starting body weight. In comparison, the standard care group gained an average of 2.6 kg.

Three different surgical approaches were used: Roux-en-Y gastric bypass (the most common, performed in 75% of cases), sleeve gastrectomy (15%), and laparoscopic gastric banding (10%).

One of the most practical findings was a reduction in insulin requirements for the surgery group. Because people weighed less after surgery, they needed less total insulin. More importantly, when researchers calculated insulin needs relative to body weight, the surgery group still showed lower insulin requirements—suggesting the surgery may have affected how insulin works in the body, beyond just the effect of weight loss itself.

However, hemoglobin A1C levels—the standard measure of average blood sugar control over three months—remained stable in both groups and did not improve after surgery. This means bariatric surgery did not make blood sugar control better or worse in this study population.

Beyond insulin and blood sugar, the research team looked at cardiovascular risk factors. The bariatric surgery group showed improvements in triglyceride levels and blood pressure. These are meaningful findings, as high triglycerides and elevated blood pressure increase the risk of heart disease.

LDL cholesterol ('bad' cholesterol) levels remained unchanged in both groups.

This study suggests that bariatric surgery can produce significant, sustained weight loss in people with Type 1 diabetes and help reduce insulin needs and certain cardiovascular risk factors. The stability of blood sugar control is reassuring—the surgery did not destabilize diabetes management.

However, this was a relatively small study (40 people total) conducted at one specialized diabetes center. Questions remain about how bariatric surgery affects different populations with Type 1 diabetes, whether the benefits persist beyond three years, and how individual factors (like how long someone has had diabetes or their starting A1C level) influence outcomes. Anyone considering bariatric surgery should discuss the specific risks, benefits, and alternatives with their diabetes care team.

Source: Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.